Nanorx Inc. minimizes bias in Metadichol research by outsourcing all experimental work to independent third-party laboratories across multiple countries on a fee-for-service basis. These labs conduct all assays, including assays and qRT-PCR and Western blotting RNA and Micro ray and sequencing methods etc without involvement from Nanorx employees, reducing procedural and observer bias compared to typical industry-sponsored research. The company transparently discloses the author’s financial interest in Nanorx Inc. and provides detailed experimental methodologies, enhancing credibility. This approach strengthens objectivity, independent validation.